FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA/DEA Warn Online Opioid Marketers

[ Price : $8.95]

FDA and the U.S. Drug Enforcement Administration issue joint Warning Letters to four online networks that were illegally marketing...

FDA Clears CivaTech Skin Cancer Patch

[ Price : $8.95]

FDA clears a CivaTech Oncology 510(k) for its CivaDerm, a radiation therapy bandage designed for intraoperative or surface radiati...

U.S. Specialty Formulations Cited on Inspection

[ Price : $8.95]

FDA posts an 11-item Form FDA-483 to U.S. Specialty Formulations after concluding an inspection of its Bethlehem, PA manufacturing...

FDA Review on Amalgam Finds No Direct Safety Concern

[ Price : $8.95]

A new FDA literature review on dental amalgam safety finds no sufficient evidence of a relationship between clinically detectable ...

Fee for Pediatric Priority Review Voucher

[ Price : $8.95]

Federal Register notice: FDA announces the fee rate of $2,167,116 for using a pediatric disease priority review voucher for fiscal...

Medical Countermeasure Priority Review Voucher

[ Price : $8.95]

Federal Register notice: FDA announces the fee rate of $2,167,116 for using a material threat medical countermeasure priority revi...

Avanir Pharma Charged in Marketing Scheme

[ Price : $8.95]

The government charges Avanir Pharmaceuticals and four individuals for paying kickbacks to a physician to induce prescribing of it...

Guide on Patient-Focused Drug Development

[ Price : $8.95]

FDA posts a draft guidance on Patient-Focused Drug Development: Methods to Identify What Is Important to Patients.

Guide on Device Software Policy Changes

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance on Changes to Existing Medical Software Policies Resulting From Sect...

FDA Cites Kowa Pharma DTC Video

[ Price : $8.95]

CDERs Office of Prescription Drug Promotion cites a Kowa Pharmaceuticals America direct-to-consumer patient testimonial video mont...